Table 1 The correlation between eIF3a expression and clinical characteristics of DLBCL patients
Characteristics | No. of patients | eIF3a expression | P value | |
|---|---|---|---|---|
Positive | Negative | |||
Age(years) | ||||
≤ 60 > 60 | 17 27 | 13 24 | 4 3 | 0.501 |
Gender | ||||
Male Female | 26 18 | 22 15 | 4 3 | 1.000 |
Ann Arbor stage | ||||
I or II III or IV | 14 30 | 9 28 | 5 2 | 0.044 |
Albumin | ||||
< 40 g/L ≥ 40 g/L | 26 18 | 24 13 | 2 5 | 0.170 |
Serum LDH | ||||
Normal Elevated | 20 24 | 15 22 | 5 2 | 0.275 |
IPI score | ||||
0–2 3–5 | 16 28 | 10 27 | 6 1 | 0.011 |
Anemia | ||||
YES NO | 14 30 | 12 25 | 2 5 | 1.000 |
Fibrinogen | ||||
≤ 4 g/L > 4 g/L | 24 20 | 19 18 | 5 2 | 0.572 |
LMR | ||||
≤ 2.25 > 2.25 | 16 28 | 12 25 | 4 3 | 0.413 |